Liposomal vitamin C is absorbed better than standard ascorbic acid.
5 sources: 4 positive, 1 partly.
Researchers say
No researcher counted yet.
Studies show
4 positive, 1 partly
5 papers we read
-
Other primary study, Nutr Metab Insights, 2016, PMID 27375360
Positive Study
Read the paper on PubMed →We have demonstrated that oral delivery of vitamin C encapsulated in liposomes promotes greater bioavailability than unencapsulated vitamin C, while avoiding the risks associated with intravenous administration.
-
Other primary study, ACS Omega, 2021, PMID 33681596
Positive Study
Read the paper on PubMed →AUC0-t was found to be 55.23 (mg/dL) for Zeal-AA, whereas it was 9.38 (mg/dL) for AA, and C max was found to be 6.69 (mg/dL) for Zeal-AA, whereas it was 1.23 (mg/dL) for AA, with a fold difference of bioavailability in terms of AUC found to be 5.9 fold.
-
Other primary study, RSC Adv, 2021, PMID 35498071
Positive Study
Read the paper on PubMed →Further human studies demonstrated >7-fold enhancement in the oral bioavailability of ascorbate with a significant improvement in pharmacokinetic properties (C max, T max, T 1/2, and AUC), compared to the unformulated counterpart (UF-CAAS) when supplemented at an equivalent dose of 400 mg of CAAS as tablets and capsules.
-
Controlled trial, Eur J Nutr, 2024, PMID 39237620
Positive Study
Read the paper on PubMed →Liposomal vitamin C significantly increased maximum plasma (+ 27%) and leukocytes (+ 20%) concentrations compared to non-liposomal vitamin C over a period of 24 h.
-
Controlled trial, Nutrients, 2023, PMID 37447400
Partly Study
Read the paper on PubMed →However, vitamin C levels were significantly increased with all treatments after 4 and 6 h with no differences among treatments.
3 more not counted · see why
The study is not yet read in full. 2
The study cited could not be identified. 1
Show the receipts from 5 sources
-
Other primary study, Nutr Metab Insights, 2016, PMID 27375360 Study · positive
We have demonstrated that oral delivery of vitamin C encapsulated in liposomes promotes greater bioavailability than unencapsulated vitamin C, while avoiding the risks associated with intravenous administration.
-
Other primary study, ACS Omega, 2021, PMID 33681596 Study · positive
AUC0-t was found to be 55.23 (mg/dL) for Zeal-AA, whereas it was 9.38 (mg/dL) for AA, and C max was found to be 6.69 (mg/dL) for Zeal-AA, whereas it was 1.23 (mg/dL) for AA, with a fold difference of bioavailability in terms of AUC found to be 5.9 fold.
-
Other primary study, RSC Adv, 2021, PMID 35498071 Study · positive
Further human studies demonstrated >7-fold enhancement in the oral bioavailability of ascorbate with a significant improvement in pharmacokinetic properties (C max, T max, T 1/2, and AUC), compared to the unformulated counterpart (UF-CAAS) when supplemented at an equivalent dose of 400 mg of CAAS as tablets and capsules.
-
Controlled trial, Eur J Nutr, 2024, PMID 39237620 Study · positive
Liposomal vitamin C significantly increased maximum plasma (+ 27%) and leukocytes (+ 20%) concentrations compared to non-liposomal vitamin C over a period of 24 h.
-
Controlled trial, Nutrients, 2023, PMID 37447400 Study · partly
However, vitamin C levels were significantly increased with all treatments after 4 and 6 h with no differences among treatments.